TNF and colitis: Additionally, therapeutic anti-NETosis interventions, including PAD inhibitors, DNase I, and TNF-α inhibitors, have been shown to attenuate NET formation and protect mice against DSS-induced colitis, specifically by reducing intestinal inflammation, restoring intestinal integrity, and colitis-associated tumorigenesis [103,104].